Koninklijke Philips (PHG) Cash from Discontinued Operations (2009 - 2025)
Koninklijke Philips (PHG) posted quarterly Cash from Discontinued Operations of 11640435.15 for Q4 2025, up 16.21% year-over-year from 10017062.97 in Q4 2024, and little changed quarter-over-quarter from 11690550.91 in Q3 2025.
Koninklijke Philips (PHG) Cash from Discontinued Operations (2009 - 2025) Analysis & Trends
Koninklijke Philips' Cash from Discontinued Operations history runs 17 years deep, the most recent figure standing at 11640435.15 for Q4 2025.
- In Q4 2025, Cash from Discontinued Operations rose 16.21% year-over-year to 11640435.15; the TTM figure through Dec 2025 stood at 45169427.34 (up 34.85% YoY), while the FY2024 annual figure was 13891740.2, down 110.5% from the prior year.
- Cash from Discontinued Operations for Q4 2025 stood at 11640435.15, roughly flat from 11690550.91 in the prior quarter.
- The five-year high for Cash from Discontinued Operations was 4552049064.24 in Q3 2021, with the low at 49382859.61 in Q1 2022.
- The 5-year median for Cash from Discontinued Operations is 10919220.64 (2025), against an average of 424989288.8.
- The sharpest annual moves came in 2021 and 2024: Cash from Discontinued Operations soared 2431.08% in 2021, then tumbled 330.16% in 2024.
- Koninklijke Philips' Cash from Discontinued Operations stood at 3892933146.71 in 2021, then sank by 100.31% to 12242968.38 in 2022, then soared by 275.76% to 21518798.18 in 2023, then plunged by 164.56% to 13891740.2 in 2024, then grew by 16.21% to 11640435.15 in 2025.
- Business Quant data shows PHG's Cash from Discontinued Operations at 11640435.15 in Q4 2025, 11690550.91 in Q3 2025, and 11319596.88 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.64 Mn |
| Dec 31, 2025 | -11.64 Mn |
| Sep 30, 2025 | -11.69 Mn |
| Sep 30, 2025 | -11.69 Mn |
| Jun 30, 2025 | -11.32 Mn |
| Jun 30, 2025 | -11.32 Mn |
| Mar 31, 2025 | -10.52 Mn |
| Mar 31, 2025 | -10.52 Mn |
| Dec 31, 2024 | -13.89 Mn |
| Dec 31, 2024 | -13.89 Mn |
| Sep 30, 2024 | -18.67 Mn |
| Sep 30, 2024 | -18.67 Mn |
| Jun 30, 2024 | -18.31 Mn |
| Jun 30, 2024 | -18.31 Mn |
| Mar 31, 2024 | -18.47 Mn |
| Mar 31, 2024 | -18.47 Mn |
| Dec 31, 2023 | 21.52 Mn |
| Dec 31, 2023 | 21.52 Mn |
| Sep 30, 2023 | 87.09 Mn |
| Sep 30, 2023 | 87.09 Mn |